chr2-240878099-A-G

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000030.3(AGXT):ā€‹c.1020A>Gā€‹(p.Ile340Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.189 in 1,613,084 control chromosomes in the GnomAD database, including 30,860 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā˜…ā˜…).

Frequency

Genomes: š‘“ 0.15 ( 2129 hom., cov: 33)
Exomes š‘“: 0.19 ( 28731 hom. )

Consequence

AGXT
NM_000030.3 missense

Scores

18

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts U:1B:11O:1

Conservation

PhyloP100: 2.93
Variant links:
Genes affected
AGXT (HGNC:341): (alanine--glyoxylate aminotransferase) This gene is expressed only in the liver and the encoded protein is localized mostly in the peroxisomes, where it is involved in glyoxylate detoxification. Mutations in this gene, some of which alter subcellular targetting, have been associated with type I primary hyperoxaluria. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0022816956).
BP6
Variant 2-240878099-A-G is Benign according to our data. Variant chr2-240878099-A-G is described in ClinVar as [Likely_benign]. Clinvar id is 39486.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-240878099-A-G is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.201 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
AGXTNM_000030.3 linkuse as main transcriptc.1020A>G p.Ile340Met missense_variant 10/11 ENST00000307503.4 NP_000021.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
AGXTENST00000307503.4 linkuse as main transcriptc.1020A>G p.Ile340Met missense_variant 10/111 NM_000030.3 ENSP00000302620 P1
AGXTENST00000470255.1 linkuse as main transcriptn.798A>G non_coding_transcript_exon_variant 2/32

Frequencies

GnomAD3 genomes
AF:
0.153
AC:
23240
AN:
152056
Hom.:
2127
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0618
Gnomad AMI
AF:
0.248
Gnomad AMR
AF:
0.136
Gnomad ASJ
AF:
0.189
Gnomad EAS
AF:
0.0751
Gnomad SAS
AF:
0.104
Gnomad FIN
AF:
0.242
Gnomad MID
AF:
0.187
Gnomad NFE
AF:
0.204
Gnomad OTH
AF:
0.167
GnomAD3 exomes
AF:
0.164
AC:
41095
AN:
250624
Hom.:
3837
AF XY:
0.166
AC XY:
22450
AN XY:
135544
show subpopulations
Gnomad AFR exome
AF:
0.0629
Gnomad AMR exome
AF:
0.106
Gnomad ASJ exome
AF:
0.196
Gnomad EAS exome
AF:
0.0857
Gnomad SAS exome
AF:
0.102
Gnomad FIN exome
AF:
0.250
Gnomad NFE exome
AF:
0.206
Gnomad OTH exome
AF:
0.180
GnomAD4 exome
AF:
0.193
AC:
281700
AN:
1460910
Hom.:
28731
Cov.:
34
AF XY:
0.190
AC XY:
138282
AN XY:
726764
show subpopulations
Gnomad4 AFR exome
AF:
0.0617
Gnomad4 AMR exome
AF:
0.107
Gnomad4 ASJ exome
AF:
0.193
Gnomad4 EAS exome
AF:
0.0777
Gnomad4 SAS exome
AF:
0.106
Gnomad4 FIN exome
AF:
0.244
Gnomad4 NFE exome
AF:
0.210
Gnomad4 OTH exome
AF:
0.178
GnomAD4 genome
AF:
0.153
AC:
23245
AN:
152174
Hom.:
2129
Cov.:
33
AF XY:
0.152
AC XY:
11317
AN XY:
74378
show subpopulations
Gnomad4 AFR
AF:
0.0619
Gnomad4 AMR
AF:
0.136
Gnomad4 ASJ
AF:
0.189
Gnomad4 EAS
AF:
0.0751
Gnomad4 SAS
AF:
0.105
Gnomad4 FIN
AF:
0.242
Gnomad4 NFE
AF:
0.204
Gnomad4 OTH
AF:
0.165
Alfa
AF:
0.189
Hom.:
5764
Bravo
AF:
0.143
TwinsUK
AF:
0.214
AC:
793
ALSPAC
AF:
0.204
AC:
786
ESP6500AA
AF:
0.0640
AC:
282
ESP6500EA
AF:
0.208
AC:
1788
ExAC
AF:
0.164
AC:
19922
Asia WGS
AF:
0.0730
AC:
254
AN:
3478
EpiCase
AF:
0.206
EpiControl
AF:
0.202

ClinVar

Significance: Benign/Likely benign
Submissions summary: Uncertain:1Benign:11Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Primary hyperoxaluria, type I Uncertain:1Benign:6Other:1
Benign, no assertion criteria providedliterature onlyOMIMSep 01, 2004- -
not provided, no classification providedliterature onlyGeneReviews-- -
Likely benign, criteria provided, single submitterclinical testingMendelicsMay 28, 2019- -
Likely benign, criteria provided, single submitterclinical testingFulgent Genetics, Fulgent GeneticsNov 17, 2021- -
Uncertain significance, no assertion criteria providedin vitroClinical Biochemistry Laboratory, Health Services LaboratoryNov 27, 2014- -
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabJul 10, 2021- -
Benign, no assertion criteria providedclinical testingNatera, Inc.Oct 30, 2019- -
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaMar 06, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
not provided Benign:3
Benign, criteria provided, single submitterclinical testingGeneDxAug 07, 2018This variant is associated with the following publications: (PMID: 1703535, 33457257, 24205397, 30341509, 28906061, 15802217) -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -
Likely benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
not specified Benign:2
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Jun 26, 2016- -
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.053
BayesDel_addAF
Benign
-0.54
T
BayesDel_noAF
Benign
-0.40
CADD
Benign
0.50
DANN
Benign
0.091
DEOGEN2
Benign
0.26
T
Eigen
Benign
-1.6
Eigen_PC
Benign
-1.4
FATHMM_MKL
Benign
0.049
N
LIST_S2
Benign
0.23
T
MetaRNN
Benign
0.0023
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
-2.2
N
MutationTaster
Benign
1.0
P
PrimateAI
Benign
0.40
T
PROVEAN
Benign
3.2
N
REVEL
Benign
0.27
Sift
Benign
1.0
T
Sift4G
Benign
1.0
T
Polyphen
0.0
B
Vest4
0.054
MPC
0.033
ClinPred
0.0076
T
GERP RS
2.2
Varity_R
0.32
gMVP
0.76

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs4426527; hg19: chr2-241817516; COSMIC: COSV56753667; COSMIC: COSV56753667; API